Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Volanesorsen
IONIS PHARMACEUTICALS INC
Abnormalities, Cardiovascular
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux Disease
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Healthy Participants
2 trials -
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Healthy Volunteers
2 trials -
Vonoprazan ODT-1 or ODT-2 without Water
Phathom Pharmaceuticals
Healthy Volunteers
1 trial -
Vyxeos
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Vyxeos 44 MG / 100 MG Liposome Injection
Jazz Pharmaceuticals Ireland Limited
Relapsed Pediatric AML
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Healthy
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Melanoma
1 trial -
XEN901
Xenon Pharmaceuticals
Healthy Volunteers
1 trial -
XM17
Teva Pharma GmbH
Bioequivalence
1 trial -
XPF-001
Xenon Pharmaceuticals
Healthy Human Volunteers
1 trial -
XPF-008
Xenon Pharmaceuticals
Healthy Male Volunteers
1 trial -
XPF-008
Xenon Pharmaceuticals
Healthy Volunteers
1 trial -
XTL 6865
XTL BIOPHARMACEUTICALS LTD
Hepatitis C
1 trial -
XTL-2125
XTL BIOPHARMACEUTICALS LTD
Chronic Hepatitis C Virus Infection
1 trial -
XeriSol glucagon
Xeris Biopharma Holdings
Type1diabetes
1 trial -
Y150
Wuhan YZY Biopharma Co.,
Relapsed or Refractory Multiple Myeloma
1 trial -
YN001
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Cardiovascular Diseases
1 trial -
Yimitasvir Phosphate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hepatic Impairment
1 trial -
Yimitasvir Phosphate Capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Impairment
1 trial -
Z650
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Pancreatic Cancer
1 trial -
ZB001 for injection
Zenas BioPharma
Healthy Volunteers
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources